Leerink analyst Joseph Schwartz upgraded Gossamer Bio Inc. (NASDAQ: GOSS) from Market Perform to Outperform with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Upgrades